The award recognizes our M&A advisory work and client commitment.
In a year with extraordinary market conditions, Gorrissen Federspiel advised on transactions valued at more then EUR 16 bn, including Chr. Hansens merger with Novozymes, Telias sale of its Danish activities to Norlys, A.P. Møller Maersks divestment of Maersk Supply Service, Novo Nordisks acquisition of Embark Biotech, Schouws acquisition of Enics, Nordic Capitals acquisition of Risk Point and Matas acquisition of Kicks.